These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2861072)

  • 1. Beta-blockers and glucose control.
    Mills GA; Horn JR
    Drug Intell Clin Pharm; 1985 Apr; 19(4):246-51. PubMed ID: 2861072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
    Popp DA; Shah SD; Cryer PE
    J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenergic blockade and hypoglycaemia.
    Lager I
    Acta Med Scand Suppl; 1983; 672():63-7. PubMed ID: 6138936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of tight intraoperative glycemic control during off-pump coronary artery bypass surgery in diabetic and nondiabetic patients.
    Lecomte P; Foubert L; Coddens J; Dewulf B; Nobels F; Casselman F; Cammu G
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):937-42. PubMed ID: 21640613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Control of blood sugar and beta blockers in the diabetic patient].
    Albert J; Ekoe JM
    Sem Hop; 1983 Nov; 59(42):2939-43. PubMed ID: 6140758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relevance of glucose counterregulatory systems to patients with insulin-dependent diabetes mellitus.
    Cryer PE; White NH; Santiago JV
    Endocr Rev; 1986 May; 7(2):131-9. PubMed ID: 2873031
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
    Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
    J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-adrenergic blockade and diabetes mellitus. A review.
    Ostman J
    Acta Med Scand Suppl; 1983; 672():69-77. PubMed ID: 6138937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood glucose counter-regulation].
    Bosquet F; Grimaldi A
    Ann Med Interne (Paris); 1985; 136(2):145-53. PubMed ID: 2866744
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanism of the blunted glucagon response to insulin-induced hypoglycemia in diabetics].
    Katsura M
    Nihon Naibunpi Gakkai Zasshi; 1986 Nov; 62(11):1276-88. PubMed ID: 3542595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.
    Bogardus C; Lillioja S; Howard BV; Reaven G; Mott D
    J Clin Invest; 1984 Oct; 74(4):1238-46. PubMed ID: 6384267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic consequences of adrenergic blockade: a reveiw.
    Day JL
    Metabolism; 1975 Aug; 24(8):987-96. PubMed ID: 238094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Prior Use of Beta-Blockers for Preventing Adverse Influences of Severe Hypoglycemia in Patients With Diabetes: An Observational Study.
    Tsujimoto T; Yamamoto-Honda R; Kajio H; Kishimoto M; Noto H; Hachiya R; Kimura A; Kakei M; Noda M
    Medicine (Baltimore); 2015 Sep; 94(39):e1629. PubMed ID: 26426649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal counterregulation during severe hypoglycaemia under everyday conditions in patients with type 1 and insulin-treated type 2 diabetes mellitus.
    Holstein A; Hammer C; Plaschke A; Ptak M; Kuhn J; Diekmann J; Kleesiek K; Egberts EH
    Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):429-34. PubMed ID: 15372362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet function and stress hyperglycemia: plasma glucose and epinephrine interaction.
    Halter JB; Beard JC; Porte D
    Am J Physiol; 1984 Jul; 247(1 Pt 1):E47-52. PubMed ID: 6377920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic mechanisms of hypoglycemic counterregulation.
    Hoffman RP
    Curr Diabetes Rev; 2007 Aug; 3(3):185-93. PubMed ID: 18220670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.